human epidermal growth factor - Globe Thesis

Keyword [human epidermal growth factor] Result: 101 - 120 \| Page: 6 of 8
101.	Expression And Significance Of HER2,ERCC1,TS In Serum AFP Positive Gastric Cancer
102.	The Observation Of Clinic Effect Of Recombinant Human Epidermal Growth Factor Combined With Vacuum Sealing Drainagetreatment On Leg Bone Exposed Wounds In Old People
103.	The Analysis Of Diagnosis And Treatment In HER2 Positive Breast Cancer
104.	Clinical Observation Of MEBO Combined With RhEGF In The Treatment Of Burn Wounds
105.	Study Of Plasma CtDNA Detection In The Treatment Of Advanced Non-small Cell Lung Cancer Patients With EGFR-TKI
106.	Application Value Of Stretched Exponential DWI In Breast Lesions
107.	Analysis Of Efficacy Of First-line Treatment For Advanced Breast Cancer Patients With Hormone Receptor Positive And Human Epidermal Growth Factor Receptor 2 Negative
108.	Correlation Between Positive HER-2 Breast Cancer Stem Cells And Drug Resistance Of Breast Cancer MDA-MB-468 Cells
109.	The Research Of Correlation Between The HER2 Expression And The Clinicopathological Characteristics And Prognosis Of Early Breast Cancer Patients Undergoing Trastuzumab-containing Therapy
110.	Application Of Magnetic Resonance Nanoparticles In HER-2 Positive Breast Cancer
111.	Efficacy And Prognosis Of Trastuzumab With Or After Neoadjuvant Chemotherapy For HER2-positive Breast Cancer
112.	HER2 Protein Expression Correlates With Lauren Classification And P53 In Gastric Cancer Patients
113.	Bayesian Analysis Of Clinical Efficacy Of Recombinant Human Epidermal Growth Factor And Recombinant Human Platelet- Derived Growth Factor In The Treatment Of Diabetic Foot Ulcer
114.	Efficacy Of Paclitaxel And Albumin-bound Paclitaxel In Neoadjuvant Chemotherapy For Human Epidermal Growth Factor Receptor-2(HER2)Negative Breast Cancer
115.	Human/rat HER2-specific Exosome-targeted T Cell Vaccine For HER2~+ Breast Cancer Immunotherapy
116.	Clinical Analysis Of Lapatinib In Combination With Capecitabine Versus Continued Use Of Trastuzumab In Advanced HER2-positive Breast Cancer Patients With Trastuzumab-resistance
117.	Expression And Clinical Significance Of MSI And PD-L1 In HER2-positive Gastric Cancer
118.	Correlation Study On The Expression Of HER2 And Ki67 In Breast Cancer With Their Ultrasound Signs
119.	High Expression Of HER-2 Is A Risk Factor For Poor Prognosis Of Colorectal Cancer
120.	Prognostic Role Of Human Epidermal-growth-factor Receptor 2(HER-2) In Colorectal Cancer
<<First <Prev Next> Last>> Jump to